Shah Pratik
Design Therapeutics, Inc. · President
Shah Pratik is listed in public filings as director, officer: President, CEO and Chairperson. This Shah Pratik insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Design Therapeutics, Inc. (DSGN), and ARS Pharmaceuticals, Inc. (SPRY). Investors use Shah Pratik's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $6.8M750k shares | Grant / ExerciseJan 2, 2026 | $6.8M750k shares | $9.10 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.3M525k shares | Grant / ExerciseDec 9, 2025 | $1.3M525k shares | $2.48 | -- | |
| --4.5M shares | Grant / ExerciseNov 12, 2025 | Disclosure amount unavailable100k shares | -- | -- | |
| --4.6M shares | Grant / ExerciseNov 12, 2025 | Disclosure amount unavailable250k shares | -- | -- | |
| $518k30k shares | Grant / ExerciseJun 25, 2025 | $517.8K30k shares | $17.26 | -- | |
| $3.7M600k shares | Grant / ExerciseJan 2, 2025 | $3.7M600k shares | $6.17 | -- | |
| $309k40k shares | Grant / ExerciseJun 20, 2024 | $309.2K40k shares | $7.73 | -- | |
| --1.1M shares | Grant / ExerciseJun 13, 2024 | Disclosure amount unavailable1.1M shares | -- | -- | |
| --1.1M shares | Grant / ExerciseJun 13, 2024 | Disclosure amount unavailable200k shares | -- | -- |